Oct. 22, 2021 Price forecast | 2 weeks: -2.01% | 1 month: -2.17% | 3 months: -6.21%


ARWR stock forecast

Our latest prediction for Arrowhead Pharmaceuticals Inc.'s stock price was made on the Oct. 22, 2021 when the stock price was at 66.03$.

In the short term (2weeks), ARWR's stock price should underperform the market by -2.01%. During that period the price should oscillate between -8.41% and +7.22%.

In the medium term (3months), ARWR's stock price should underperform the market by -6.21%. During that period the price should oscillate between -29.64% and +18.30%.

Create a solid portfolio with ARWR

Add ARWR to your portfolio and optimize it!


About Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Arrowhead's RNAi-based therapeutics leverage this natural pathway of gene silencing.

At the moment the company generates 108M USD in revenues.

On its last earning announcement, the company reported a loss of -1.23$ per share.

The book value per share is 1.15$

Arrowhead Pharmaceuticals Inc. website


Three months stock forecastOct. 22, 2021


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
108M 100.00% -134M -124.70% -126M -1.23 - - 103M 1.15 184M -17M 167M